AxoGen, Inc. ( AXGN) - Stock Earnings
AXGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
AXGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -13.2 million USD | 59.9 million USD |
| 2026Q1 | -19.6 million USD | 61.5 million USD |
| 2026Q2 | -1.5 million USD | 69.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AXGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.7 million USD | 159.0 million USD |
| 2024 | -10.0 million USD | 187.3 million USD |
| 2025 | -15.7 million USD | 225.2 million USD |
| 2026 Est. | — | — |
AXGN
Price: $36.13
Dividend Yield: 2.25%
Earnings Per Share: -0.68 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 233500
Ebitda: -1.4 millionMarket Capitalization: 2.0 billion